Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of preventing or reducing adverse reactions to protamine using a thromboxane A.sub.2 receptor antagonist

Method of preventing or reducing adverse reactions to protamine using a thromboxane A.sub.2 receptor antagonist

US Patent 5066480 · Granted Nov 19, 1991

Estimated economic value: $55,038,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antimicrobial metallic touch surfaces and methods for making the same2024
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin2022
Method for joining dissimilar metals and articles comprising the same2020
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin2018
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin2018
Commonized electrical grounding device2017
Method for noribogaine treatment in patients on methadone2017
Reduced-corrosion fastened assembly2017
Methods and compositions for pre-screening patients for treatment with noribogai2017
Oral formulations of mitochondrially-targeted antioxidants and their preparation2017
Low dose noribogaine for treating nicotine addiction and preventing relapse of n2017
Use of ibogaine for the treatment of pain2017